Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether pharmacogenomic study predict
antidepressant responsiveness in advance before the appearance of the drug effects until 4~6
weeks after drug administration.